We are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Our lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to […]

(IPOScoop has “NO CALL” on this offering because it is NOT a traditional IPO. This is a direct listing on the New York Stock Exchange. This offering does not have underwriters. Instead, the investment banks named here are acting as financial advisors.) *Note: The NYSE set a reference price of $18.00 for the ZipRecruiter direct listing, […]

TransCode Therapeutics is an emerging RNA oncology company, created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics. We have created a platform of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes. Our lead therapeutic candidate, […]

Biotech and life sciences companies are the intended acquisition targets of this new blank check company. (Incorporated in the Cayman Islands.)

We cultivate and process natural, medicinal-grade cannabis oil and high quality cannabis derived medical and wellbeing products and intend to supply these premium products to large channel distributors, including pharmacies, medical clinics, and cosmetic companies. We are an early-stage private company headquartered in Canada.  Our agricultural and processing operations are in Colombia.  We are an […]

Maquia Capital Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination throughout this prospectus. We have not selected any specific business […]

We intend to focus our search on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business focusing on the data centers and internet technology sectors where our management team has extensive experience. (Note: Data Knights Acquisition Corp. priced its SPAC IPO […]

We intend to focus on target businesses within the Greater China region, especially on companies within technology-enabled sectors, including but not limited to: e-commerce, enterprise software and cloud computing, and FinTech. (Incorporated in the Cayman Islands) Simon Xie, a co-founder of Alibaba Group, is a co-founder of Angel Pond Holdings Corp.  The SPAC’s other co-founder is Theodore […]

We intend to focus on established businesses that have an aggregate enterprise value of approximately $800 million to $2 billion and would benefit from access to public markets and the operational and strategic expertise of our management team and board of directors. We will seek to capitalize on the significant experience of our management team in consummating […]

(Note: Genworth Financial revived its Enact Holdings spin-off’s IPO in early August with a new underwriting lineup and filed terms in an S-1/A filing dated Sept. 13, 2021. Genworth Financial is the selling stockholder; Genworth is offering all of the 13.31 million shares in the IPO. Enact Holdings will not receive any of the IPO […]